"The number one advantage regarding Nevisense is that it backs up my decision and provides me with more certainty in whether or not to excise a lesion"Dr. Isabel Gahlen, Ludwigsburg, Germany
Changes in SciBase’s financial calendar for 2020March 26, 2020SciBase Holding AB ("SciBase" or the "Company") has updated the Company's financial calendar for 2020. Due to the preparation of the rights issue announced earlier today, the Company has r...
Notice of an Extraordinary General Meeting of SciBase Holding AB (publ)
The shareholders of SciBase Holding AB (publ), reg. no. 556773-4768, are hereby invited to an extraordinary general meeting on Wednesday, April 29, 2020 at 10.00 a.m. CET at Setterwalls Advokatbyrå's premises at Sturegatan 10 in Stockholm, Sweden. Registration for the meeting commences 30 minutes prior to the opening of the meeting.
The board of directors of SciBase has resolved on a fully guaranteed rights issue of units consisting of shares and warrants, subject to the approval of a general meeting
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
- Load more news...